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1. Introduction 
Naturally occurring and synthetic thiazole derivatives 
find applications as antioxidants [1], antibacterial drugs 
[2-4] and fungicidal treatment [5,6]. Anti-inflammatory, 
analgesic and antipyretic activities are known for some 
thiazolyl and benzothiazolyl derivatives [7-9]. These 
compounds are able to block cartilage destruction during 
the inflammatory process and thus are a promising class 
of anti-inflammatory compounds [10]. 
    The use of 2-aminothiazole derivatives as inhibitors 
of human cancer and Alzheimer’s disease was studied 
and developed [11-15]. 2-Aminothiazole-5-carboxylates 
are an important class of heterocycles in organic 
chemistry, especially in the preparation of biologically 
and medicinally useful agents such as angiotensin 
II antagonists, DNA minor groove binding analogs of 
netropsin [16]. The antitumor activity of some thiazole 
derivatives for example thiazole nucleoside tiazofurin, 
distamycin, netropsin, thia-netropsin- with binding 
properties to DNA and the thiazole containing antitumor 
agent bleomycin was reported. Ethyl 2-substituted-
aminothiazole-4-carboxylate analogs were tested for 
their in vitro antitumor activity against human tumor cell 
lines. Ethyl 2-[3(diethylamino)propanamido]-thiazole-4-
carboxylate exhibited remarkable activity against RPMI-
8226 leukemia cell line [17]. 
Only few studies have been published related to 
complex compounds with 2-aminothiazole derivatives 
which presented coordination geometry of the metal ion 
of tetrahedral type for Zn(II), Co(II) [18,19], Cd(II) [20], 
and octahedral type for Co(II) [21]. The complex of Ru(III) 
with ethyl 2-amino-4-phenyl-5-thiazolecarboxylate 
showed significant antileukaemic activity on various 
human cells [22] and also Keppler-type ruthenium(III) 
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complexes like 2-aminothiazolium[trans-tetrachlorobis(2-
aminothiazole)ruthenate(III)] exhibit promising antitumor 
properties [23].
In this work, we synthesized and characterized 
four new complex compounds of Cu(II), Co(II), Zn(II) 
and Mn(II), respectively with thiazole derivative L1 
(2-aminothiazole-4-acetate) obtained from ethyl 2-(2-
aminothiazole-4-yl)acetate, L which hydrolyzed during 
the synthesis. Cytotoxicity of L as well as [Cu(L1)2] (1) 
and [Mn(L1)2(H2O)] (4) on HeLa cells and on PBMC 
have also been determined.
2. Experimental Procedure
All reagents and solvents (Sigma-Aldrich), were of 
analytical grade and used without further purification. 
Complete medium for cell growth and the reagents for 
cytotoxicity studies were purchased from Sigma-Aldrich 
(Taufkirchen, Germany).
Synthesis of L1: NaOH and L, molar ratio 1,5:1 were 
mixed in water-ethanol as solvent and kept under reflux 
for 5 h. The solvent was evaporated and the precipitate 
resulted was recrystallized from water.    
Synthesis of complex (1): 0.372 g (2 mmoles) of L 
dissolved in EtOH were added to an aqueous solution 
of 0.17 g (1 mmole) CuCl2•2H2O. The solution was kept 
under stirring at 500C for 2 h. The brown precipitate was 
filtered off, washed with EtOH and dried under vacuum. 
Yield: 55%. Anal Found (%): Cu, 16.52; C, 32.10; H, 
2.60; N, 15.06. Calculated for CuC10H10N4O4S2 (%): Cu, 
16.82; C, 31.78; H, 2.65; N, 14.83. σ (µS cm-1): 34, non-
electrolyte.  
Synthesis of complex (2) and complex (3): The 
complexes were prepared as described for complex (1), 
using 0.372 g L and 0.238, and 0.24 g of CoCl2•6H2O 
and ZnCl2, respectively.
The complex (2) was obtained as a light pink solid. 
Yield: 60%. Anal Found (%): Co, 15.14; C, 32.31; H, 
3.02; N, 15.12. Calculated for CoC10H10N4O4S2 (%): Co, 
15.81; C, 32.17; H, 2.68; N, 15.01. σ (µS cm-1): 42, non-
electrolyte.  
The complex (3) was isolated as a white solid. 
Yield: 56%. Anal Found (%): Zn, 17.06; C, 31.50; H, 
Figure 1. X-ray structure of [Mn(L1)2(H2O)]
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2.87; N, 14.23. Calculated for ZnC10H10N4O4S2 (%): Zn, 
17.15; C, 31.66; H, 2.64; N, 14.77. σ (µS cm-1): 28, non-
electrolyte.  
Synthesis of complex (4): 0.372 g (2 mmoles) of L 
dissolved in EtOH was added to an aqueous solution of 
0.24 g (1 mmole) of Mn(CH3COO)2•2H2O. The solution 
was kept under stirring at 50 0C for 2 h. The light 
brown precipitate was filtered off, washed with EtOH 
and dried under vacuum. Yield: 53%. Anal Found (%): 
Mn, 14.15; C, 30.93; H, 3.41; N, 14.65. Calculated for 
MnC10H12N4O5S2 (%): Mn, 14.21; C, 31.01; H, 3.10; N, 
Figure 3. 1H-NMR spectra of L, [Zn(L1)2] and L1
14.47. σ (µS cm-1): 46, non-electrolyte.  
The elemental analysis was performed on a Perkin-
Elmer Series II CHNS/ O Analyser 2400. 1H-NMR 
spectra were recorded on a Gemini 300 BB operating 
at 300 MHz in DMSO-d6 using TMS as internal 
standard. UV-Vis reflectance spectra were recorded 
on Jasco V-560 spectrophotometer and IR spectra on 
a FT-IR Bruker VERTEX 70 equipped with a diamond 
ATR. Electrical molar conductivities were measured 
in N,N-dimethylformamide (10-3 M solution) on OK-
114 RADELKIS Conductometer at 250C. Magnetic 
measurements were carried out with a Faraday balance 
at room temperature using Mohr salt as standard. X-ray 
diffraction measurements were performed on a STOE-
IPDS II diffractometer. The structures were solved 
(SHELXS-97) by direct methods and refined (SHELXL-
97) by full matrix least-square procedures on F2 [25]. 
Crystallographic data for the structural analysis have 
been deposited with the Cambridge Crystallographic 
Data Centre, CCDC No. 755831.
2.1. Cytotoxicity assays on HeLa cells
(HeLa cells (human cervical carcinoma cell line)  were 
cultured in triplicate in a 96-well plate at 37°C under 5% 
CO2 in 100 μL of growth medium, RPMI 1640 (Sigma-
Aldrich, Taufkirchen, Germany) supplemented with 
10 % fetal calf serum (FCS) (Sigma-Aldrich), 2 mM 
glutamine (Sigma-Aldrich), 100 IU mL-1 penicillin and 
100 IU mL-1  streptomycin (Sigma-Aldrich). The Hela 
cells were seeded as 2000 cells/well and after 24 h, 
serial dilutions of the compounds are added. The ligand 
and the complex compounds (1) and (4) were dissolved 
in DMSO and the solutions were diluted by nutrient 
medium, RPMI 1640, containing 10% FCS.
Table 1.  Crystal data and structure refinement for [Mn(L1)2(H2O)]
Formula weight                            386.31 
Temperature                                297(2) K 
Wavelength                                  0.71073 Å  
Crystal system, space group        Monoclinic,  C2/c   
Unit cell dimensions            a = 12.1567(17) Å  alpha = 90 deg. 
                                             b = 9.4915(13) Å beta = 94.556(2)deg. 
                                             c = 12.7295(18) Å   gamma = 90 deg. 
Volume                                   1464.2(4) Å3 
Z, Calculated density              4,  1.752 g cm-3 
Absorption coefficient             1.215 mm-1 
F(000)                                     784 
Crystal size                             0.52×0.16×0.15 mm 
Theta range for data collection        2.73 to 24.99 deg. 
Limiting indices                      -14<=h<=14, -11<=k<=11, -15<=l<=15 
Reflections collected / unique          6785 / 1285 [R(int) = 0.0471] 
Completeness to theta = 24.99       99.9% 
Absorption correction                      Semi-empirical from equivalents 
Max. and min. transmission             0.8388 and 0.5707 
Refinement method                         Full-matrix least-squares on F2 
Data / restraints / parameters         1285 / 2 / 110 
Goodness-of-fit on F2                     1.272 
Final R indices [I>2sigma(I)]           R1 = 0.0630, wR2 = 0.1135 
R indices (all data)                          R1 = 0.0695, wR2 = 0.1163 
D–H...A d(D–H) d(H...A) d(D...A) ∠(DHA) Symmetry transformations 
O(3)–H(3)...O(2) 0.82 1.88 2.654 (5) 157 ½+x, ½+y, z
N(2)–H(10)...O(2) 0.85 (4) 2.02 (4) 2.849 (6) 168 (4) 3/2-x, 1/2-y,1-z
N(2)–H(11)...O(1) 0.85 (5) 2.13 (4) 2.916(6) 153 (6)
Table 2. Hydrogen bonds for (4) (Åand deg.)
    After allowing cells to adhere to the plate for 24 h, 
the medium was removed and the compounds were 
added to the wells at different concentrations in the 
range 0,01-100 μM for the ligand and 0,001-10 μM 
for compound (1) and 0,5-500 μM for compound (4). 
For the compounds to take effect freshly prepared 
compounds solutions were incubated for 24 h at 37°C 
under 5% CO2. Cytotoxicity was evaluated using MTT 
assay (Sigma-Aldrich). A solution of MTT 5mg ml-1 in 
phosphate buffered saline (PBS) was added to each well 
and mixed with the suspensions followed by incubation 
to allow the metabolization of MTT. After the incubation, 
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the medium was removed and the formazan (MTT 
metabolic product) resuspended and thoroughly mixed 
in 100 μL DMSO. The optical densities were read at 
540 nm and the background substracted at 670 nm using 
an Elisa microreader. The measure of the cytotoxicity of 
the compounds both in PHA/PBMC and HeLa cells is an 
IC50 value (calculated as the concentration of the tested 
compound needed to reduce cell viability for 50% when 
compared to the control cells).
2.2. Preparation and treatment of PBMC
Peripheral blood mononuclear cells (PBMCs) were 
isolated from a healthy donor by Ficoll (Amersham 
Biosciences) density gradient centrifugation. PBMCs 
(2×105) were cultured in duplicates in 96-well Nunclone 
plates in 200 µL of RPMI 1640 medium supplemented 
with 10% fetal calf serum (FCS) (Sigma-Aldrich), 2 mM 
glutamine (Sigma-Aldrich), 50 µM β-mercaptoethanol 
(Sigma-Aldrich), 25 µg mL-1 gentamicin, 100 IU mL-1 
penicillin and 100 IU mL-1 streptomycin (Sigma-Aldrich) 
at 37oC and 5% CO2 in a humidified atmosphere. Cells 
were stimulated with a mitogen, phytohaemaglutinin 
(PHA) (0.5 µg/mL).  The final concentrations of the 
compounds in cell suspension ranged between 0,001-
100 μM (L) 0,0001-10 μM (1), 0,5-500 μM for (4). Cell 
survival was determined by MTT test [26-28]. 
PHA/PBMC cultures with serial dilutions of the 
compounds were incubated for 76 h in a humidified 
atmosphere at 37oC, before addition of the MTT reagent. 
The MTT metabolic product, formazan, solubilizes in 
DMSO and absorbs at 540 nm. Optical density was read 
at 540 nm and background subtracted at 670 nm using 
an Elisa microplate reader.
3. Results and Discussion
The complex compound was synthesized from aqueous 
solutions of metal salts MCl2•xH2O, where M(II)= Cu, 
Co, Zn, x= 2, 6, 0 and Mn(CH3COO)2•4H2O which was 
mixed with methanol solutions of L (1: 2, metal: ligand 
ratio).
Ethyl 2-(2-aminothiazole-4-yl)acetate, L, hydrolyzed 
in the aqueous solutions and in the presence of metal 
ions, conditions in which ligand L1 was generated. Thus 
the complex compounds contain L1 that was synthesized 
and characterized independently. The hydrolysis of the 
ester group from L was recently noticed by Zhang et al. 
[24].   
3.1. X-ray crystallography
X-ray structure was determined for complex compound 
(4), [Mn(L1)2(H2O)], (Fig. 1) which crystallizes in the 
centrosymmetric space group C2/c with a R value of 
0.06. Crystal data and structure refinement details 
are given in Table 1. Mn atom has distorted square 
pyramidal coordination geometry water molecule in 
axial position and two ligand molecules in equatorial 
plane coordinating through N1, N1a, O1, O1a atoms. 
Interatomic distances are Mn(1)–N(1) 2.175(4), Mn(1)–
О(1) 2.106(3) and Mn(1)-O(3) 2.081(5) Å. The packing 
of the structure is based on intermolecular hydrogen 
bonding between the unit cells. Hydrogen bond lengths 
and angles are presented in Table 2. Also, the distance 
(3,566(3) Å) between the mean planes suggests the 
existence of π-π stacking interactions between the 
neighboring thiazole rings. 
Table 3. FTIR bands and assignments
     L         L1  (1)  (2)   (3)   (4)             Assignment 
   3277          3256  3294  3291  3289  3289          νsimNH2
   3115          3079  3096  3095  3094  3094          νsimCH (thiazole)
   2990                   νasimCH3
   2903                   νsimCH3
   1711                   νC=O 
          1591  1574  1578  1579  1578          νasimCOO-
   1621          1619  1634  1632  1634  1634          νC=N
   1521          1515  1511  1511  1514  1514          δthiazole
          1391  1398  1410  1411  1399          νsimCOO-
   1312          1323  1358  1364  1365  1365          δC-H
   1245          1291  1289  1290  1288  1288          νC-O 
   1126          1119  1127  1129  1130  1130          νC-N
    977           973  940  943  940  941          νS-C
   431  434  435  436         νM-N, M (II)= Cu, Co, Zn, Mn
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3.2. UV-Vis spectroscopy 
UV-Vis spectra of the solid powders of L and complex 
compounds (1), (2), (3), (4) are shown in Fig. 2. UV-
Vis spectrum of compound (1) shows a wide LMCT 
type band at 470 nm. The bands at 450 nm and 
550 nm of compound (2) can be assigned to 4T1g 
←4T1g(P) (ν2) and 4T1g ←4A2g (ν3) d-d transitions, 
characteristic for Co(II) in tetrahedral symmetry. 
The UV-Vis spectrum for compound (4) contains a 
large band at 370 nm assigned to LMCT process.
 
3.3. IR spectroscopy
IR spectra were recorded for the ligand and the 
complexes in order to determine the coordination 
manner. The assignments of the IR bands are presented 
in Table 3. Disappearance of vibration band C=O 
(ester group) from the IR spectra of L1 and of complex 
compounds (1)- (4) which appeared at 1711 cm-1 in the 
IR spectrum of L, confirm the hydrolysis of L. Also the 
asymmetric and symmetric vibration bands of carboxyl 
group present in the IR spectrum of L1 at 1591 cm-1, 
1391 cm-1 respectively, and in the IR spectra of the 
complex compounds at 1574, 1398 cm-1 (1), 1578, 
1410 cm-1 (2), 1579, 1411 cm-1 (3) and 1578, 1399 cm-1 
(4) demonstrates the hydrolysis of L1. A significant 
difference between IR spectra of the ligand L1 and the 
coordination compounds is the position of C=N vibration 
band which is shifted from 1619 cm-1 (L1) to higher 
frequencies 1634 cm-1 (1), 1632 cm-1 (2), 1634 cm-1 (3), 
1634 cm-1 (4), due to the coordination of the endo-N 
atom to the metal ions.
3.4.  1H- NMR spectroscopy
Aliphatic proton signals from the ester group are 
shown only in the 1H-NMR spectrum of L as opposed 
to 1H-NMR spectra of L1 and (3) due to ethyl 2-(2-
aminothiazole-4-yl)acetate, L, hydrolysis. Another 
important difference between 1H-NMR spectra of L, L1 
and the complex compound is the shift of amino protons 
Figure 4. Representative graphs showing survival of tumor cells HeLa grown for 48 h in the presence of increasing concentrations of the complexes  
          (1) and (4) determined by MTT test
Table 4.  Magnetic moments of the compounds
Compound Magnetic susceptibility         Magnetic moment, μB Theoretical magnetic moment, μB
                                     106*∠Xg, cm
3 g-1
 
     (1)                   2,6                            1,92           1,73
       (2)                   16                  4,39           3,87
       (3)                   <0                    ≈0              0
       (4)                   32                  6,42           5,92
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signals from 7,21 ppm (L), 6,90 ppm (L1) to 8,44 ppm 
(3). Also the signal of aromatic proton from the thiazole
 ring from L1 suffers a small displacement from 6,19 ppm 
(L1) to 6,28 ppm for the complex compound [Zn(L1)2], 
Fig. 3.   
3.5. Magnetic measurements
The values of the experimental magnetic moments are 
very close to theoretical values (Table 4). The values 
of the magnetic moments of the (2) and (4) support the 
high spin tetrahedral distorted configurations which are 
in accordance with the appearance of UV-Vis spectra. 
Compound (3) displays diamagnetic behaviour.
 
3.6.Viability assessments 
The EC50 values were determined by extrapolation from 
cell viability curves. Fig. 4 contains two representative 
graphs for cytotoxic activity of (1) and (4) on HeLa cella. 
The EC50 values are presented in Table 5.  
The viability increases along with the    decrease 
of the concentration of the compounds. The ligand (L) 
does not show high cytotoxicity in any of the cultures 
tested. The presence of the metal ions in coordination 
compounds (1) and (4) greatly increased its cytotoxicity 
in comparison with the ligand, especially on HeLa cells. 
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